Production (Stage)
Mustang Bio, Inc.
MBIO
$1.24
-$0.01-0.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 83.93% | 32.48% | 82.80% | -57.95% | 39.75% |
| Total Depreciation and Amortization | -45.33% | 47.06% | 5,000.00% | -99.86% | 91.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -106.70% | 2,845.07% | -96.28% | 2,411.84% | -93.09% |
| Change in Net Operating Assets | 64.59% | -584.65% | -111.86% | 538.36% | -793.07% |
| Cash from Operations | 30.45% | -13.66% | 24.75% | 56.12% | 26.65% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 36.93% | 378.25% | -80.44% | 12,034.69% | -98.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -320.13% | 78.09% | -- | -- |
| Cash from Financing | 54.29% | 386.79% | -80.74% | 10,646.94% | -98.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.51% | 495.56% | -125.35% | 155.60% | -58.41% |